53 results
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
and in connection with the transactions contemplated hereby, including without limitation (i) all expenses incident to the issuance and delivery of the Shares … in the offering and distribution of the Shares; (viii) the filing fees incident to FINRA review, if any; (ix) the costs and expenses of the Company relating
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
28 May 21
Entry into a Material Definitive Agreement
5:03pm
with the transactions contemplated hereby, including without limitation (i) all expenses incident to the issuance and delivery of the Shares (including all … and distribution of the Shares; (viii) the filing fees incident to FINRA review, if any; (ix) the costs and expenses of the Company relating to investor
8-K
EX-1.1
im4zzz4p
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
8-K
EX-1.1
nu428d
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
8-K
EX-1.1
a7ww7z1gmfpxh 9l
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
8-K
EX-10.1
1z9 lcuy1q
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
8-K
EX-10.1
0y9oe8n
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
424B3
45176
8 May 19
Prospectus supplement
12:00am
S-4/A
ocjulf518 frbv
3 May 19
Registration of securities issued in business combination transactions (amended)
9:51pm
S-4
EX-10.47
myclo
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
EX-10.50
q7nluhu o526u6vx
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
83oc4vyaa7
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm